Condition (MeSH)
Limbic Encephalitis
ClinicalTrials.gov lists 4 trials for Limbic Encephalitis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Limbic Encephalitis itself; the rest are tagged with a narrower condition beneath it.
When did Limbic Encephalitis trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2015 | 2 |
| 2014 | 1 |
| 2011 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 4 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Limbic Encephalitis trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Not applicable | 1 |
| Observational | 2 |
How many Limbic Encephalitis trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Limbic Encephalitis? (19)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. | Neurology | 2016 | Yes |
| Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. | Neurology | 2016 | Yes |
| Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis. | Journal of neurology, neurosurgery, and psychiatry | 2015 | Yes |
| Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis. | Journal of neuroimmunology | 2014 | Yes |
| Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. | The Journal of neuroscience : the official journal of the Society for Neuroscience | 2013 | Yes |
Showing 5 of 19 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.